/PRNewswire/ Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage biopharmaceutical company focused on developing cell therapies for.
Kyverna Therapeutics, Inc. (Kyverna), a patient-centered clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, today announced it.
/PRNewswire/ Kyverna Therapeutics ("Kyverna"), a clinical-stage cell therapy company with the mission of engineering a new class of therapies for serious.
/PRNewswire/ Kyverna Therapeutics ("Kyverna"), announced today its participation in the Morgan Stanley 21st Annual Global Healthcare Conference to be held.